20 results on '"Thastrup J"'
Search Results
2. P-257 In vitro drug screening of patient-derived 3D tumoroids replicates resistance to FOLFOX, FOLFIRI, and FOLFOXIRI in clinically resistant patients with metastatic colorectal cancer
- Author
-
Hagel, G., primary, Thastrup, O., additional, Rafaelsen, S., additional, Thastrup, J., additional, and Lindebjerg, J., additional
- Published
- 2022
- Full Text
- View/download PDF
3. Pre-therapeutic Evaluation of Patient-Specific Responses to Immune-Checkpoint Inhibition in Colorectal Cancer
- Author
-
Sturmheit, T., primary, Konczalla, L., additional, Temovski, T. Sutus, additional, Günther, A., additional, Brauneck, F., additional, Li, J., additional, Perez, D., additional, Jücker, M., additional, Thastrup, J., additional, Fiedler, W., additional, Wellbrock, J., additional, Kupper, J., additional, and Block, A., additional
- Published
- 2019
- Full Text
- View/download PDF
4. 3D micro-tumors for predicting individual treatment responses to immunotherapy
- Author
-
Sturmheit, T., primary, Stamm, H., additional, Stange, I., additional, Köllmann, S., additional, Failla, A.V., additional, Thastrup, J., additional, Fiedler, W., additional, Kupper, J., additional, and Block, A., additional
- Published
- 2019
- Full Text
- View/download PDF
5. 165P - Pre-therapeutic Evaluation of Patient-Specific Responses to Immune-Checkpoint Inhibition in Colorectal Cancer
- Author
-
Sturmheit, T., Konczalla, L., Temovski, T. Sutus, Günther, A., Brauneck, F., Li, J., Perez, D., Jücker, M., Thastrup, J., Fiedler, W., Wellbrock, J., Kupper, J., and Block, A.
- Published
- 2019
- Full Text
- View/download PDF
6. Structural insights into the recognition of substrates and activators by the OSR1 kinase
- Author
-
Villa, F., primary, Goebel, J., additional, Rafiqi, F.H., additional, Deak, M., additional, Thastrup, J., additional, Alessi, D.R., additional, and van Aalten, D.M.F., additional
- Published
- 2007
- Full Text
- View/download PDF
7. JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways
- Author
-
Dietrich, N, primary, Thastrup, J, additional, Holmberg, C, additional, Gyrd-Hansen, M, additional, Fehrenbacher, N, additional, Lademann, U, additional, Lerdrup, M, additional, Herdegen, T, additional, Jäättelä, M, additional, and Kallunki, T, additional
- Published
- 2003
- Full Text
- View/download PDF
8. JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways.
- Author
-
Dietrich, N, Thastrup, J, Holmberg, C, Gyrd-Hansen, M, Fehrenbacher, N, Lademann, U, Lerdrup, M, Herdegen, T, Jäättelä, M, and Kallunki, T
- Subjects
- *
TUMOR necrosis factors , *APOPTOSIS , *CYTOCHROME c , *CELL death , *FIBROBLASTS , *CYTOKINES - Abstract
Recent studies strongly suggest an active involvement of the c-Jun N-terminal kinase (JNK) signaling pathway in tumor necrosis factor (TNF)-induced apoptosis. The direct evidence for the role of JNK and its isoforms has been missing and the mechanism of how JNK actually could facilitate this process has remained unclear. In this study, we show that Jnk2-/- primary mouse embryonic fibroblasts (pMEFs) exhibit resistance towards TNF-induced apoptosis as compared to corresponding wild-type and Jnk1-/- pMEFs. JNK2-deficient pMEFs could be resensitized to TNF via retroviral transduction of any of the four different JNK2 splicing variants. Jnk2-/- pMEFs displayed deficient and delayed effector caspase activation as well as impaired cytosolic cystein cathepsin activity: processes that both were needed for efficient TNF-induced apoptosis in pMEFs. Our work demonstrates that JNK has a central role in the promotion of TNF-induced apoptosis in pMEFs, and that the JNK2 isoform can regulate both mitochondrial and lysosomal death pathways in these cells.Cell Death and Differentiation (2004) 11, 301-313. doi:10.1038/sj.cdd.4401353 Published online 12 December 2003 [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
9. The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
- Author
-
Truelsen SLB, Mousavi N, Wei H, Harvey L, Stausholm R, Spillum E, Hagel G, Qvortrup K, Thastrup O, Harling H, Mellor H, and Thastrup J
- Subjects
- Aged, Aged, 80 and over, Angiogenesis Inducing Agents pharmacology, Cell Line, Tumor, Colorectal Neoplasms drug therapy, Colorectal Neoplasms pathology, Female, Fibroblast Growth Factors pharmacology, Fibroblasts drug effects, Human Umbilical Vein Endothelial Cells drug effects, Humans, In Vitro Techniques, Male, Middle Aged, Platelet-Derived Growth Factor pharmacology, Spheroids, Cellular drug effects, Vascular Endothelial Growth Factor A pharmacology, Angiogenesis Inhibitors pharmacology, Coculture Techniques methods, Neovascularization, Pathologic drug therapy
- Abstract
The treatment response to anti-angiogenic agents varies among cancer patients and predictive biomarkers are needed to identify patients with resistant cancer or guide the choice of anti-angiogenic treatment. We present "the Cancer Angiogenesis Co-Culture (CACC) assay", an in vitro Functional Precision Medicine assay which enables the study of tumouroid induced angiogenesis. This assay can quantify the ability of a patient-derived tumouroid to induce vascularization by measuring the induction of tube formation in a co-culture of vascular cells and tumoroids established from the primary colorectal tumour or a metastasis. Furthermore, the assay can quantify the sensitivity of patient-derived tumoroids to anti-angiogenic therapies. We observed that tube formation increased in a dose-dependent manner upon treatment with the pro-angiogenic factor vascular endothelial growth factor A (VEGF-A). When investigating the angiogenic potential of tumoroids from 12 patients we found that 9 tumoroid cultures induced a significant increase in tube formation compared to controls without tumoroids. In these 9 angiogenic tumoroid cultures the tube formation could be abolished by treatment with one or more of the investigated anti-angiogenic agents. The 3 non-angiogenic tumoroid cultures secreted VEGF-A but we observed no correlation between the amount of tube formation and tumoroid-secreted VEGF-A. Our data suggests that the CACC assay recapitulates the complexity of tumour angiogenesis, and when clinically verified, could prove a valuable tool to quantify sensitivity towards different anti-angiogenic agents., Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: SLBT, GH, OT, RS and JT are fulltime employees at 2cureX, Symbion, Copenhagen, Denmark. GH and OT are founders and stockholders for 2cureX. ES is a fulltime employee at BioSense Solutions, Farum, Denmark. ES is a founder and stockholders for BioSense Solutions. This does not alter our adherence to PLOS ONE policies on sharing data and materials. NM, HW, LH, KQ, HH and HM declare no competing interests.
- Published
- 2021
- Full Text
- View/download PDF
10. In Vitro Coculture Assays of Angiogenesis.
- Author
-
Wei H, Sundararaman A, Truelsen SLB, Gurevich D, Thastrup J, and Mellor H
- Subjects
- Cell Communication physiology, Cells, Cultured, Fibroblasts cytology, Human Umbilical Vein Endothelial Cells cytology, Humans, Biological Assay methods, Coculture Techniques methods, Neovascularization, Pathologic pathology
- Abstract
During angiogenesis, endothelial cells must undergo a coordinated set of morphological changes in order to form a new vessel. There is a need for endothelial cells to communicate with each other in order to take up different identities in the sprout and to migrate collectively as a connected chord. Endothelial cells must also interact with a wide range of other cells that contribute to vessel formation. In ischemic disease, hypoxic cells in tissue will generate proangiogenic signals that promote and guide angiogenesis. In solid tumors, this function is co-opted by tumor cells, which make a complex range of interactions with endothelial cells, even integrating into the walls of vessels. In vessel repair, cells from the immune system contribute to the promotion and remodeling of new vessels. The coculture angiogenesis assay is a long-term in vitro protocol that uses fibroblasts to secrete and condition an artificial stromal matrix for tubules to grow through. We show here how the assay can be easily adapted to include additional cell types, facilitating the study of cellular interactions during neovascularization.
- Published
- 2021
- Full Text
- View/download PDF
11. Application of digital image analysis on histological images of a murine embryoid body model for monitoring endothelial differentiation.
- Author
-
Mousavi N, Raft MB, Truelsen SLB, Timmermans V, Thastrup J, and Heegaard S
- Subjects
- Animals, Image Processing, Computer-Assisted, Mice, Cell Differentiation physiology, Embryoid Bodies cytology, Endothelium embryology, Pluripotent Stem Cells cytology
- Abstract
The in vitro 3D model established from murine pluripotential stem cells (i.e., embryoid bodies (EBs)) is a dynamic model for endothelial differentiation. The aim of the present study was to investigate whether digital image analysis (DIA) can be applied on histological sections of EBs in order to quantify endothelial differentiation over time. The EBs were established in suspension cultures for 21 days in three independent replicate experiments. At day 4, 6, 9, 14, 18, and 21, the EBs were fixed in formaldehyde, embedded in paraffin and immunohistochemically (IHC) stained for CD31. The IHC-stained slides were digitally scanned and analysed using the Visiopharm® Quantitative Digital Pathology software Oncotopix™. The EBs developed CD31+ vascular-like structures during their differentiation. The quantitative DIA of the EBs showed that the log10 values of the relative CD31+ areas increased from -0.574 ± 0.470 (mean ± SD) at day 4 to 0.093 ± 0.688 (mean ± SD) at day 21 (p < 0.001). The approach presented in this study is a fast, quantitative and reproducible alternative method for an otherwise time-consuming and observer-dependent histological investigation. The future perspectives for such a system would be implementation of a modified version of the method on different 3D cultures and IHC markers., (Copyright © 2020 Elsevier GmbH. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
12. KRAS mutations in the parental tumour accelerate in vitro growth of tumoroids established from colorectal adenocarcinoma.
- Author
-
Mousavi N, Truelsen SLB, Hagel G, Jorgensen LN, Harling H, Timmermans V, Melchior LC, Thysen AH, Heegaard S, and Thastrup J
- Subjects
- Aged, Aged, 80 and over, DNA Mutational Analysis methods, Female, Genetic Predisposition to Disease, High-Throughput Nucleotide Sequencing, Humans, Male, Middle Aged, Organoids, Phenotype, Time Factors, Tumor Cells, Cultured, Adenocarcinoma genetics, Adenocarcinoma secondary, Cell Proliferation, Colorectal Neoplasms genetics, Colorectal Neoplasms pathology, Mutation, Proto-Oncogene Proteins p21(ras) genetics
- Abstract
The aim of the present study was to characterize a patient-derived in vitro 3D model (ie tumoroid) established from colorectal adenocarcinoma. This study investigated the growth rate of tumoroids and whether the Kirsten rat sarcoma (KRAS) mutations in the parental tumour accelerate this rate. The tumoroids were established from surgical resections of primary and metastatic colorectal adenocarcinoma from 26 patients. The in vitro growth rate of these tumoroids was monitored by automated imaging and recorded as relative growth rate. The KRAS hotspot mutations were investigated on the parental tumours by Ion Torrent
™ next-generation sequencing. The KRAS mutations were detected in 58% of the parental tumours, and a significantly higher growth rate was observed for tumoroids established from the KRAS-mutated tumours compared to wild-type tumours (P < 0.0001). The average relative growth rate (log10) on day 10 was 0.360 ± 0.180 (mean ± SD) for the KRAS-mutated group and 0.098 ± 0.135 (mean ± SD) for the KRAS wild-type group. These results showed that the presence of KRAS mutations in parental tumours is associated with an acceleration of the growth rate of tumoroids. The future perspective for such a model could be the implementation of chemoassays for personalized medicine., (© 2019 The Authors. International Journal of Experimental Pathology © 2019 International Journal of Experimental Pathology.)- Published
- 2019
- Full Text
- View/download PDF
13. Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient-derived spheroid cultures.
- Author
-
Árnadóttir SS, Jeppesen M, Lamy P, Bramsen JB, Nordentoft I, Knudsen M, Vang S, Madsen MR, Thastrup O, Thastrup J, and L Andersen C
- Subjects
- Aged, Aged, 80 and over, Biopsy, Colorectal Neoplasms pathology, Female, Humans, Lymph Nodes pathology, Lymphatic Metastasis pathology, Male, Middle Aged, Mutation, Phylogeny, Sequence Analysis, RNA, Spheroids, Cellular cytology, Tumor Cells, Cultured, Exome Sequencing, Colorectal Neoplasms genetics, Genetic Heterogeneity, Spheroids, Cellular pathology
- Abstract
Patient-derived in vitro cultures of colorectal cancer (CRC) may help guide treatment strategies prior to patient treatment. However, most previous studies have been performed on a single biopsy per tumor. The purpose of this study was to analyze multiple spatially distinct biopsies from CRCs and see how well intratumor heterogeneity (ITH) was recapitulated in matching patient-derived spheroids. Three to five biopsies were collected from six CRC tumors. Each biopsy was split in two; one half was used for spheroid culturing, while the other half was used for DNA and RNA purification. For two patients, lymph node metastases were analyzed. Somatic mutations were called from whole exome sequencing data. Each tumor contained mutations shared across all biopsies and spheroids, including major CRC drivers such as APC, KRAS, and TP53. At the same time, all tumors exhibited ITH on both mutation and copy number level. The concordance between biopsies and spheroids ranged between 40 and 70% for coding mutations. For three patients, the biopsy and spheroid from matching areas clustered together, meaning that the spheroid resembled the area of origin more than the other areas. However, all biopsies and spheroids contained private mutations. Therefore, multiple cultures from spatially distinct sites of the tumor increase the insight into the genetic profile of the entire tumor. Molecular subtypes were called from RNA sequencing data. When based on transcripts from both cancer and noncancerous cells, the subtypes were largely independent of sampling site. In contrast, subtyping based on cancer cell transcripts alone was dependent on sample site and genetic ITH. In conclusion, all examined CRC tumors showed genetic ITH. Spheroid cultures partly reflected this ITH, and having multiple cultures from distinct tumor sites improved the representation of the genetic tumor subclones. This should be taken into account when establishing patient-derived models for drug screening., (© 2017 The Authors. Published by FEBS Press and John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
14. Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine.
- Author
-
Jeppesen M, Hagel G, Glenthoj A, Vainer B, Ibsen P, Harling H, Thastrup O, Jørgensen LN, and Thastrup J
- Subjects
- Adenocarcinoma pathology, Cell Proliferation, Cell Survival, Epithelial Cells pathology, Fibroblasts pathology, Humans, Keratin-20 metabolism, Neoplasm Proteins metabolism, Tumor Cells, Cultured, Colorectal Neoplasms pathology, Models, Biological, Precision Medicine, Spheroids, Cellular pathology
- Abstract
Chemotherapy treatment of cancer remains a challenge due to the molecular and functional heterogeneity displayed by tumours originating from the same cell type. The pronounced heterogeneity makes it difficult for oncologists to devise an effective therapeutic strategy for the patient. One approach for increasing treatment efficacy is to test the chemosensitivity of cancer cells obtained from the patient's tumour. 3D culture represents a promising method for modelling patient tumours in vitro. The aim of this study was therefore to evaluate how closely short-term spheroid cultures of primary colorectal cancer cells resemble the original tumour. Colorectal cancer cells were isolated from human tumour tissue and cultured as spheroids. Spheroid cultures were established with a high success rate and remained viable for at least 10 days. The spheroids exhibited significant growth over a period of 7 days and no difference in growth rate was observed for spheroids of different sizes. Comparison of spheroids with the original tumour revealed that spheroid culture generally preserved adenocarcinoma histology and expression patterns of cytokeratin 20 and carcinoembryonic antigen. Interestingly, spheroids had a tendency to resemble tumour protein expression more closely after 10 days of culture compared to 3 days. Chemosensitivity screening using spheroids from five patients demonstrated individual response profiles. This indicates that the spheroids maintained patient-to-patient differences in sensitivity towards the drugs and combinations most commonly used for treatment of colorectal cancer. In summary, short-term spheroid culture of primary colorectal adenocarcinoma cells represents a promising in vitro model for use in personalized medicine.
- Published
- 2017
- Full Text
- View/download PDF
15. Solid-phase synthesis of smac peptidomimetics incorporating triazoloprolines and biarylalanines.
- Author
-
Le Quement ST, Ishoey M, Petersen MT, Thastrup J, Hagel G, and Nielsen TE
- Subjects
- Alanine analogs & derivatives, Alkynes chemistry, Azides chemistry, Catalysis, Copper chemistry, Hydrocarbons, Aromatic chemistry, Inhibitor of Apoptosis Proteins chemistry, Inhibitor of Apoptosis Proteins pharmacology, Models, Chemical, Oligopeptides chemistry, Oligopeptides pharmacology, Palladium chemistry, Peptidomimetics chemistry, Peptidomimetics pharmacology, Proline analogs & derivatives, Triazoles chemistry, Alanine chemistry, Inhibitor of Apoptosis Proteins chemical synthesis, Oligopeptides chemical synthesis, Peptidomimetics chemical synthesis, Proline chemistry, Solid-Phase Synthesis Techniques methods
- Abstract
Apoptotic induction mechanisms are of crucial importance for the general homeostasis of multicellular organisms. In cancer the apoptotic pathways are downregulated, which, at least partly, is due to an abundance of inhibitors of apoptosis proteins (IAPs) that block the apoptotic cascade by deactivating proteolytic caspases. The Smac protein has an antagonistic effect on IAPs, thus providing structural clues for the synthesis of new pro-apoptotic compounds. Herein, we report a solid-phase approach for the synthesis of Smac-derived tetrapeptide libraries. On the basis of a common (N-Me)AVPF sequence, peptides incorporating triazoloprolines and biarylalanines were synthesized by means of Cu(I)-catalyzed azide-alkyne cycloaddition and Pd-catalyzed Suzuki cross-coupling reactions. Solid-phase procedures were optimized to high efficiency, thus accessing all products in excellent crude purities and yields (both typically above 90%). The peptides were subjected to biological evaluation in a live/dead cellular assay which revealed that structural decorations on the AVPF sequence indeed are highly important for cytotoxicity toward HeLa cells.
- Published
- 2011
- Full Text
- View/download PDF
16. Identification of nucleolar effects in JNK-deficient cells.
- Author
-
Mialon A, Thastrup J, Kallunki T, Mannermaa L, Westermarck J, and Holmström TH
- Subjects
- Active Transport, Cell Nucleus, Animals, Humans, JNK Mitogen-Activated Protein Kinases genetics, Mice, Mice, Knockout, Phosphorylation, Protein Biosynthesis, RNA, Ribosomal metabolism, Signal Transduction, Cell Nucleolus enzymology, DEAD-box RNA Helicases metabolism, JNK Mitogen-Activated Protein Kinases metabolism
- Abstract
The c-Jun N-terminal kinase (JNK) signalling pathway has an established role in cellular stress signalling, cell survival and tumorigenesis. Here, we demonstrate that inhibition of JNK signalling results in partial delocalization of the RNA helicase DDX21 from the nucleolus to the nucleoplasm, increased nucleolar mobility of DDX21 and inhibition of rRNA processing. Furthermore, our results show that JNK signalling regulates DDX21 phosphorylation and protein expression. In conclusion, the results presented in this study reveal a previously unidentified cellular role for JNK signalling in the regulation of nucleolar functions. Based on these results, we propose that JNK-mediated effects on nucleolar homeostasis and rRNA processing should be considered when interpreting cellular phenotypes observed in JNK-deficient cell and animal models.
- Published
- 2008
- Full Text
- View/download PDF
17. Structural insights into the recognition of substrates and activators by the OSR1 kinase.
- Author
-
Villa F, Goebel J, Rafiqi FH, Deak M, Thastrup J, Alessi DR, and van Aalten DM
- Subjects
- Amino Acid Motifs, Amino Acid Sequence, Conserved Sequence, Crystallography, X-Ray, Humans, Models, Molecular, Molecular Sequence Data, Mutant Proteins chemistry, Mutant Proteins metabolism, Peptides chemistry, Peptides metabolism, Phosphorylation, Protein Binding, Protein Folding, Protein Structure, Tertiary, Structure-Activity Relationship, Substrate Specificity, Enzyme Activators metabolism, Protein Serine-Threonine Kinases chemistry, Protein Serine-Threonine Kinases metabolism
- Abstract
The oxidative-stress-responsive kinase 1 (OSR1) and the STE20/SPS1-related proline/alanine-rich kinase (SPAK) are key enzymes in a signalling cascade regulating the activity of Na(+)/K(+)/2Cl(-) co-transporters (NKCCs) in response to osmotic stress. Both kinases have a conserved carboxy-terminal (CCT) domain, which recognizes a unique peptide (Arg-Phe-Xaa-Val) motif present in OSR1- and SPAK-activating kinases (with-no-lysine kinase 1 (WNK1) and WNK4) as well as its substrates (NKCC1 and NKCC2). Here, we describe the structural basis of this recognition event as shown by the crystal structure of the CCT domain of OSR1 in complex with a peptide containing this motif, derived from WNK4. The CCT domain forms a novel protein fold that interacts with the Arg-Phe-Xaa-Val motif through a surface-exposed groove. An intricate web of interactions is observed between the CCT domain and an Arg-Phe-Xaa-Val motif-containing peptide derived from WNK4. Mutational analysis shows that these interactions are required for the CCT domain to bind to WNK1 and NKCC1. The CCT domain structure also shows how phosphorylation of a Ser/Thr residue preceding the Arg-Phe-Xaa-Val motif results in a steric clash, promoting its dissociation from the CCT domain. These results provide the first molecular insight into the mechanism by which the SPAK and OSR1 kinases specifically recognize their upstream activators and downstream substrates.
- Published
- 2007
- Full Text
- View/download PDF
18. Regulation of activity and localization of the WNK1 protein kinase by hyperosmotic stress.
- Author
-
Zagórska A, Pozo-Guisado E, Boudeau J, Vitari AC, Rafiqi FH, Thastrup J, Deak M, Campbell DG, Morrice NA, Prescott AR, and Alessi DR
- Subjects
- Amino Acid Sequence, Animals, Catalytic Domain drug effects, Cell Survival drug effects, Clathrin metabolism, Cytoplasmic Vesicles drug effects, Cytoplasmic Vesicles enzymology, Enzyme Activation drug effects, HeLa Cells, Humans, Intracellular Signaling Peptides and Proteins, Minor Histocompatibility Antigens, Molecular Sequence Data, Osmotic Pressure, Phosphorylation drug effects, Phosphoserine metabolism, Protein Binding drug effects, Protein Serine-Threonine Kinases chemistry, Protein Transport drug effects, Rats, Recombinant Fusion Proteins metabolism, WNK Lysine-Deficient Protein Kinase 1, Protein Serine-Threonine Kinases metabolism, Sorbitol pharmacology
- Abstract
Mutations within the WNK1 (with-no-K[Lys] kinase-1) gene cause Gordon's hypertension syndrome. Little is known about how WNK1 is regulated. We demonstrate that WNK1 is rapidly activated and phosphorylated at multiple residues after exposure of cells to hyperosmotic conditions and that activation is mediated by the phosphorylation of its T-loop Ser382 residue, possibly triggered by a transautophosphorylation reaction. Activation of WNK1 coincides with the phosphorylation and activation of two WNK1 substrates, namely, the protein kinases STE20/SPS1-related proline alanine-rich kinase (SPAK) and oxidative stress response kinase-1 (OSR1). Small interfering RNA depletion of WNK1 impairs SPAK/OSR1 activity and phosphorylation of residues targeted by WNK1. Hyperosmotic stress induces rapid redistribution of WNK1 from the cytosol to vesicular structures that may comprise trans-Golgi network (TGN)/recycling endosomes, as they display rapid movement, colocalize with clathrin, adaptor protein complex 1 (AP-1), and TGN46, but not the AP-2 plasma membrane-coated pit marker nor the endosomal markers EEA1, Hrs, and LAMP1. Mutational analysis suggests that the WNK1 C-terminal noncatalytic domain mediates vesicle localization. Our observations shed light on the mechanism by which WNK1 is regulated by hyperosmotic stress.
- Published
- 2007
- Full Text
- View/download PDF
19. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
- Author
-
Nielsen C, Thastrup J, Bøttzauw T, Jäättelä M, and Kallunki T
- Subjects
- Animals, Cell Transformation, Neoplastic genetics, Down-Regulation, Female, Genes, ras, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Nude, Mitogen-Activated Protein Kinase 9 deficiency, Mitogen-Activated Protein Kinase 9 genetics, NIH 3T3 Cells, Phosphorylation, RNA Interference, Signal Transduction, Transduction, Genetic, ras Proteins genetics, Cell Transformation, Neoplastic metabolism, Mitogen-Activated Protein Kinase 9 metabolism, Transcription Factor AP-1 metabolism, ras Proteins metabolism
- Abstract
Active Ras oncogene is expressed in approximately 30% of human cancers. Yet, very little is known about the molecular mechanisms responsible for its transforming potential. Here, we show that H-Ras-mediated transformation requires isoform 2 of the c-Jun-NH(2)-terminal kinase (JNK). H-Ras-transduced JNK2-deficient (Jnk2-/-) murine embryonic fibroblasts (MEFs) were severely inhibited in colony formation and growth in soft agar in vitro as well as in tumor formation in immunodeficient mice as compared with corresponding Jnk1-/- and wild-type MEFs. Accordingly, the RNA interference-based depletion of JNK2 form wild-type MEFs also resulted in defective Ras transformation. The extra barrier against H-Ras transformation in Jnk2-/- MEFs was not due to their inability to inactivate p53 signaling because all JNK2-deficient MEF lines had lost p19(Arf). Furthermore, expression of the E6 protein of the human papilloma virus failed to overcome the transformation defect. It could, however, be overcome by coexpression of H-Ras with the SV40 large T antigen or c-Myc. Surprisingly, the H-Ras-transduced JNK2-deficient MEFs exhibited higher activity of activator protein-1 and higher levels of c-Jun expression compared with H-Ras-transduced JNK1-deficient or wild-type cells, indicating that the key target of JNK2 during Ras transformation was divergent from activator protein-1. These results clearly show that a single kinase, JNK2, could control Ras transformation and thus point out a vulnerable control point that may prove important for the tumor development in general.
- Published
- 2007
- Full Text
- View/download PDF
20. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
- Author
-
Vitari AC, Thastrup J, Rafiqi FH, Deak M, Morrice NA, Karlsson HK, and Alessi DR
- Subjects
- Binding Sites, Cells, Cultured, Enzyme Activation, Humans, Hyperkalemia genetics, Hypertension genetics, Intracellular Signaling Peptides and Proteins, Kidney cytology, Minor Histocompatibility Antigens, Mutation, Osmolar Concentration, Phosphorylation, Sequence Homology, Amino Acid, Serine, Sodium-Potassium-Chloride Symporters, Solute Carrier Family 12, Member 2, Substrate Specificity, Threonine, WNK Lysine-Deficient Protein Kinase 1, Protein Serine-Threonine Kinases metabolism
- Abstract
The SPAK (STE20/SPS1-related proline/alanine-rich kinase) and OSR1 (oxidative stress-responsive kinase-1) kinases interact and phosphorylate NKCC1 (Na+-K+-2Cl- co-transporter-1), leading to its activation. Recent studies indicated that SPAK and OSR1 are phosphorylated and activated by the WNK1 [with no K (lysine) protein kinase-1] and WNK4, genes mutated in humans affected by Gordon's hypertension syndrome. In the present study, we have identified three residues in NKCC1 (Thr175/Thr179/Thr184 in shark or Thr203/Thr207/Thr212 in human) that are phosphorylated by SPAK and OSR1, and have developed a peptide substrate, CATCHtide (cation chloride co-transporter peptide substrate), to assess SPAK and OSR1 activity. Exposure of HEK-293 (human embryonic kidney) cells to osmotic stress, which leads to phosphorylation and activation of NKCC1, increased phosphorylation of NKCC1 at the sites targeted by SPAK/OSR1. The residues on NKCC1, phosphorylated by SPAK/OSR1, are conserved in other cation co-transporters, such as the Na+-Cl- co-transporter, the target of thiazide drugs that lower blood pressure in humans with Gordon's syndrome. Furthermore, we characterize the properties of a 92-residue CCT (conserved C-terminal) domain on SPAK and OSR1 that interacts with an RFXV (Arg-Phe-Xaa-Val) motif present in the substrate NKCC1 and its activators WNK1/WNK4. A peptide containing the RFXV motif interacts with nanomolar affinity with the CCT domains of SPAK/OSR1 and can be utilized to affinity-purify SPAK and OSR1 from cell extracts. Mutation of the arginine, phenylalanine or valine residue within this peptide abolishes binding to SPAK/OSR1. We have identified specific residues within the CCT domain that are required for interaction with the RFXV motif and have demonstrated that mutation of these in OSR1 inhibited phosphorylation of NKCC1, but not of CATCHtide which does not possess an RFXV motif. We establish that an intact CCT domain is required for WNK1 to efficiently phosphorylate and activate OSR1. These data establish that the CCT domain functions as a multipurpose docking site, enabling SPAK/OSR1 to interact with substrates (NKCC1) and activators (WNK1/WNK4).
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.